Device Cervical

Endoskeleton Tc Nanolock Surface Technology

Payments companies reported to CMS as associated with Endoskeleton Tc Nanolock Surface Technology. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$131Kassociated payments (2023-2025)
124clinicians with associated payments
1company reporting

By year

2023 $10K
2024 $15K
2025 $106K

Payments reported as associated with Endoskeleton Tc Nanolock Surface Technology, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurological Surgery $97K
Orthopaedic Surgery of The Spine $28K
Orthopaedic Surgery $4,631
Physician Assistant $1,351
Surgical $286
Acute Care (Nurse Practitioner) $167

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Endoskeleton Tc Nanolock Surface Technology

These are the largest totals companies reported as associated with Endoskeleton Tc Nanolock Surface Technology. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Jeffrey Mullin Williamsville, NY Neurological Surgery $20,875.41
Praveen Mummaneni San Francisco, CA Neurological Surgery $15,356.52
Charles Sansur Baltimore, MD Neurological Surgery $14,423.34
Andrew Grossbach Columbus, OH Neurological Surgery $13,867.29
John Shin Philadelphia, PA Neurological Surgery $12,023.46
Tiffany Perry Los Angeles, CA Neurological Surgery $11,991.81
Andrew Pugely Iowa City, IA Orthopaedic Surgery of The Spine $11,697.73
Paul Eichenseer Westerville, OH Orthopaedic Surgery of The Spine $8,177.33
Paul Slosar Daly City, CA Orthopaedic Surgery of The Spine $2,975.00
Michael Mccarthy Carmel, IN Orthopaedic Surgery of The Spine $2,648.55

Prescribed Endoskeleton Tc Nanolock Surface Technology?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.